Molecular Partners AG (MOLN)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
May 16, 16:00
Molecular Partners Shares Outstanding: 32.85M for Dec. 31, 2023
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.85M |
| December 01, 2023 | 32.85M |
| September 30, 2023 | 32.84M |
| September 01, 2023 | 32.84M |
| June 30, 2023 | 32.83M |
| March 31, 2023 | 32.56M |
| March 01, 2023 | 36.06M |
| December 31, 2022 | 36.04M |
| December 01, 2022 | 36.04M |
| October 31, 2022 | 36.01M |
| August 31, 2022 | 32.51M |
| June 30, 2022 | 32.50M |
| March 31, 2022 | 32.33M |
| December 31, 2021 | 32.29M |
| September 30, 2021 | 32.28M |
| Date | Value |
|---|---|
| June 30, 2021 | 32.27M |
| January 29, 2021 | 29.15M |
| December 31, 2020 | 29.15M |
| June 30, 2020 | 21.81M |
| December 31, 2019 | 21.60M |
| June 30, 2019 | 21.38M |
| December 31, 2018 | 21.23M |
| June 30, 2018 | 21.18M |
| December 31, 2017 | 20.72M |
| June 30, 2017 | 20.79M |
| December 31, 2016 | 20.72M |
| June 30, 2016 | 20.68M |
| December 31, 2015 | 19.58M |
| June 30, 2015 | 19.54M |
| December 31, 2014 | 19.49M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
21.38M
Minimum
Jun 30 2019
36.06M
Maximum
Mar 01 2023
31.34M
Average
32.51M
Median
Aug 31 2022
Shares Outstanding Benchmarks
| AC Immune SA | 98.90M |
| CRISPR Therapeutics AG | 84.92M |
| Addex Therapeutics Ltd | 1.069M |
| NLS Pharmaceutics Ltd | 43.32M |
| MoonLake Immunotherapeutics | 62.87M |